Evelyn Partners Investment Management LLP Novartis Ag Transaction History
Evelyn Partners Investment Management LLP
- $3.52 Trillion
- Q3 2025
A detailed history of Evelyn Partners Investment Management LLP transactions in Novartis Ag stock. As of the latest transaction made, Evelyn Partners Investment Management LLP holds 700 shares of NVS stock, worth $91,882. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700
Previous 448
56.25%
Holding current value
$91,882
Previous $84.7 Million
6.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,601Shares Held
137MCall Options Held
1.44MPut Options Held
1.87M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.01 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$950 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $282B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...